8-溴-7-丁炔-3-甲基-1-(4-甲基-喹唑啉-2-甲基)-3,7-二氢-嘌呤-2,6-二酮
8-Bromo-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-(4-methyl-2-quinazolinyl)methyl-1H-purine-2,6-dione
| 产品编号.: | A029579 | CAS号: | 853029-57-9 |
| 分子式: | C20H17BrN6O2 | 分子量: | 453.291982412338 |
| 纯度: | 99% | MDL NO.: |
中文名称：8-溴-7-丁炔-3-甲基-1-(4-甲基-喹唑啉-2-甲基)-3,7-二氢-嘌呤-2,6-二酮
CAS号：853029-57-9
中文别名：利拉利汀母核;8-溴-7-(2-丁炔)-3-甲基-1-((4-甲基喹唑啉-2-基)甲基)-黄嘌呤;8-溴-7-(2-丁炔-1-基)-3,7-二氢-3-甲基-1-((4-甲基-2-喹唑啉基)甲基)-1H-嘌呤-2,6-二酮;8-溴-7-(2-丁炔-1-基)-3,7-二氢-3-甲基-1-[(4-甲基-2-喹唑啉基)甲基]-1H-嘌呤-2,6-二酮;8-溴-7-丁炔-3-甲基-1-(4-甲基-喹唑啉-2-甲基)-3,7-二氢-嘌呤-2,6-二酮;利格列汀母核;利格列汀杂质A
英文名称：8-Bromo-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-(4-methyl-2-quinazolinyl)methyl-1H-purine-2,6-dione
英文别名：8-Bromo-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione;8-Bromo-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione;8-Bromo-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquin-azolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione;8-bromo-7-(but-2-ynyl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione;8-BROMO-7-BUT-2-YNYL-3-METHYL-1-(4-METHYL-QUINAZOLIN-2-YLMETHYL)-3,7-DIHYDRO-PURINE-2,6-DIONE;1-[(4-methyl-quinazolin-2-yl)methyl]-3-m;1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(but-2-ynyl)-8-bromo-xanthine;1H-Purine-2,6-dione,8-bromo-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl];2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione;X4789;RCZJXCXNYGHNSR-UHFFFAOYSA-N;1-[(4-Methylquinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-bromoxanthine;8-Bromo-7-(but-2-yn-1-yl)-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-3,7-dihydro-1H-pu;Linagliptin Impurity A;1H-Purine-2,6-dione, 8-bromo-7-(2-butynyl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]- (9CI);8-Bromo-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione (ACI)
EINECS:
分子式：C20H17BRN6O2
分子量：453.291982412338
CAS号：853029-57-9
中文别名：利拉利汀母核;8-溴-7-(2-丁炔)-3-甲基-1-((4-甲基喹唑啉-2-基)甲基)-黄嘌呤;8-溴-7-(2-丁炔-1-基)-3,7-二氢-3-甲基-1-((4-甲基-2-喹唑啉基)甲基)-1H-嘌呤-2,6-二酮;8-溴-7-(2-丁炔-1-基)-3,7-二氢-3-甲基-1-[(4-甲基-2-喹唑啉基)甲基]-1H-嘌呤-2,6-二酮;8-溴-7-丁炔-3-甲基-1-(4-甲基-喹唑啉-2-甲基)-3,7-二氢-嘌呤-2,6-二酮;利格列汀母核;利格列汀杂质A
英文名称：8-Bromo-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-(4-methyl-2-quinazolinyl)methyl-1H-purine-2,6-dione
英文别名：8-Bromo-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione;8-Bromo-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione;8-Bromo-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquin-azolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione;8-bromo-7-(but-2-ynyl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione;8-BROMO-7-BUT-2-YNYL-3-METHYL-1-(4-METHYL-QUINAZOLIN-2-YLMETHYL)-3,7-DIHYDRO-PURINE-2,6-DIONE;1-[(4-methyl-quinazolin-2-yl)methyl]-3-m;1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(but-2-ynyl)-8-bromo-xanthine;1H-Purine-2,6-dione,8-bromo-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl];2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione;X4789;RCZJXCXNYGHNSR-UHFFFAOYSA-N;1-[(4-Methylquinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-bromoxanthine;8-Bromo-7-(but-2-yn-1-yl)-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-3,7-dihydro-1H-pu;Linagliptin Impurity A;1H-Purine-2,6-dione, 8-bromo-7-(2-butynyl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]- (9CI);8-Bromo-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione (ACI)
EINECS:
分子式：C20H17BRN6O2
分子量：453.291982412338
搜索质检报告(COA)
搜索MSDS
相关产品
